Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).

Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W, Heussel CP, Horger M, Kurzai O, Karthaus M, Löffler J, Maschmeyer G, Penack O, Rieger C, Rickerts V, Ritter J, Schmidt-Hieber M, Schuelper N, Schwartz S, Ullmann A, Vehreschild JJ, von Lilienfeld-Toal M, Weber T, Wolf HH.

Mycoses. 2018 Nov;61(11):796-813. doi: 10.1111/myc.12838. Epub 2018 Sep 3. Review.

PMID:
30098069
2.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

3.

Advances in the diagnosis and treatment of fungal infections of the CNS.

Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M.

Lancet Neurol. 2018 Apr;17(4):362-372. doi: 10.1016/S1474-4422(18)30030-9. Epub 2018 Feb 21. Review.

PMID:
29477506
4.

Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.

Chandrasekar P, Sirohi B, Seibel NL, Hsu JW, Azie N, Wu C, Ruhnke M.

Mycoses. 2018 May;61(5):331-336. doi: 10.1111/myc.12748. Epub 2018 Feb 2.

PMID:
29364548
5.

Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA.

Ann Hematol. 2018 Feb;97(2):197-207. doi: 10.1007/s00277-017-3196-2. Epub 2017 Dec 7. Review.

6.
7.

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, Link H, Mahlberg R, Neumann S, Ostermann H, Penack O, Ruhnke M, Sandherr M, Schiel X, Vehreschild JJ, Weissinger F, Maschmeyer G.

Ann Hematol. 2017 Nov;96(11):1775-1792. doi: 10.1007/s00277-017-3098-3. Epub 2017 Aug 30. Review.

8.

[Spectrum of pathogens in postoperative complications of visceral surgery : The problem of multidrug resistance].

Kramer A, Pochhammer J, Walger P, Seifert U, Ruhnke M, Harnoss JC.

Chirurg. 2017 May;88(5):369-376. doi: 10.1007/s00104-017-0382-7. Review. German.

PMID:
28229205
9.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
10.

Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.

Ruhnke M, Schwartz S.

Ther Adv Hematol. 2016 Dec;7(6):345-359. Epub 2016 Jul 1. Review.

11.

Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Mendling W, Friese K, Mylonas I, Weissenbacher ER, Brasch J, Schaller M, Mayser P, Effendy I, Ginter-Hanselmayer G, Hof H, Cornely O, Ruhnke M.

Geburtshilfe Frauenheilkd. 2015 Apr;75(4):342-354. No abstract available.

12.

CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O, Christopeit M, Buchheidt D, Meyding-Lamadé U, Hähnel S, Wolf HH, Ruhnke M, Schwartz S, Maschmeyer G.

Ann Oncol. 2016 Jul;27(7):1207-25. doi: 10.1093/annonc/mdw155. Epub 2016 Apr 6.

13.

Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.

Hahn-Ast C, Felder L, Mayer K, Mückter S, Ruhnke M, Hein R, Hellmich M, Schwab K, Rachow T, Brossart P, von Lilienfeld-Toal M.

Ann Hematol. 2016 May;95(6):1001-9. doi: 10.1007/s00277-016-2630-1. Epub 2016 Mar 28.

PMID:
27021301
14.

Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?

Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, Bretagne S, Melchers W, Mengoli C, Caliendo AM, Cogliati M, Debets-Ossenkopp Y, Gorton R, Hagen F, Halliday C, Hamal P, Harvey-Wood K, Jaton K, Johnson G, Kidd S, Lengerova M, Lass-Florl C, Linton C, Millon L, Morrissey CO, Paholcsek M, Talento AF, Ruhnke M, Willinger B, Donnelly JP, Loeffler J; EAPCRI.

Med Mycol. 2017 Jun 1;55(4):402-413. doi: 10.1093/mmy/myw093.

PMID:
28339744
15.

Estimated burden of fungal infections in Germany.

Ruhnke M, Groll AH, Mayser P, Ullmann AJ, Mendling W, Hof H, Denning DW; University of Manchester in association with the LIFE program.

Mycoses. 2015 Oct;58 Suppl 5:22-8. doi: 10.1111/myc.12392.

PMID:
26449503
16.

[How to do: Blood culture].

Borde JP, Ruhnke M, Küpper MF, Hübner J, Kern WV.

Dtsch Med Wochenschr. 2015 Apr;140(9):666-9. doi: 10.1055/s-0041-101733. Epub 2015 Apr 29. Review. German.

PMID:
25924046
17.

Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).

Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.

Mycoses. 2015 Mar;58 Suppl 1:1-15. doi: 10.1111/myc.12292. Erratum in: Mycoses. 2015 May;58(5):324. Multiple author names added..

PMID:
25711406
18.

Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008).

Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, Velegraki A, Kibbler C, Meis JF, Sabino R, Ruhnke M, Arikan-Akdagli S, Salonen J, Dóczi I.

Clin Microbiol Infect. 2015 Jan;21(1):87.e1-87.e10. doi: 10.1016/j.cmi.2014.08.011. Epub 2014 Oct 12.

19.

Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis.

Cornely OA, Meems L, Herbrecht R, Viscoli C, van Amsterdam RG, Ruhnke M.

Mycoses. 2015 Jan;58(1):58-64. doi: 10.1111/myc.12274.

PMID:
25530265
20.

Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria.

Ruhnke M, Arnold R, Gastmeier P.

Lancet Oncol. 2014 Dec;15(13):e606-e619. doi: 10.1016/S1470-2045(14)70344-4. Epub 2014 Nov 24. Review.

PMID:
25456379
21.

Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany.

Borde JP, Litterst S, Ruhnke M, Feik R, Hübner J, deWith K, Kaier K, Kern WV.

Infection. 2015 Feb;43(1):45-50. doi: 10.1007/s15010-014-0693-2. Epub 2014 Oct 25.

PMID:
25344419
22.

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Tacke D, Buchheidt D, Karthaus M, Krause SW, Maschmeyer G, Neumann S, Ostermann H, Penack O, Rieger C, Ruhnke M, Sandherr M, Schweer KE, Ullmann AJ, Cornely OA.

Ann Hematol. 2014 Sep;93(9):1449-56. doi: 10.1007/s00277-014-2108-y. Epub 2014 Jun 21. Review.

PMID:
24951122
23.

Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital.

Borde JP, Batin N, Rieg S, Feik R, Reimling C, Kern WV, de With K, Hübner J, Ruhnke M, Kaier K.

Infection. 2014 Aug;42(4):713-9. doi: 10.1007/s15010-014-0633-1. Epub 2014 Jun 3.

PMID:
24889541
24.

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2015 Jan;26(1):21-33. doi: 10.1093/annonc/mdu192. Epub 2014 May 15.

25.

Antifungal stewardship in invasive Candida infections.

Ruhnke M.

Clin Microbiol Infect. 2014 Jun;20 Suppl 6:11-8. doi: 10.1111/1469-0691.12622. Review.

26.

Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2014 May;25(5):936-47. doi: 10.1093/annonc/mdt545. Epub 2014 Jan 7.

PMID:
24399078
27.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).

Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K, Haas B, Hahn K, Härter G, Hartmann M, Herzmann C, Hutterer J, Jordan AR, Lange C, Mauss S, Meyer-Olson D, Mosthaf F, Oette M, Reuter S, Rieger A, Rosenkranz T, Ruhnke M, Schaaf B, Schwarze S, Stellbrink HJ, Stocker H, Stoehr A, Stoll M, Träder C, Vogel M, Wagner D, Wyen C, Hoffmann C; Deutsche AIDS Gesellschaft; Österreichische AIDS-Gesellschaft.

Infection. 2013 Sep;41 Suppl 2:S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14.

28.

Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Mousset S, Buchheidt D, Heinz W, Ruhnke M, Cornely OA, Egerer G, Krüger W, Link H, Neumann S, Ostermann H, Panse J, Penack O, Rieger C, Schmidt-Hieber M, Silling G, Südhoff T, Ullmann AJ, Wolf HH, Maschmeyer G, Böhme A.

Ann Hematol. 2014 Jan;93(1):13-32. doi: 10.1007/s00277-013-1867-1. Epub 2013 Sep 12.

29.

Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment.

de Wit M, Ortner P, Lipp HP, Sehouli J, Untch M, Ruhnke M, Mayer-Steinacker R, Bokemeyer C, Jordan K.

Onkologie. 2013;36(3):127-35. doi: 10.1159/000348524. Epub 2013 Feb 25. Review.

PMID:
23486002
30.

Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis.

Liu P, Ruhnke M, Meersseman W, Paiva JA, Kantecki M, Damle B.

Antimicrob Agents Chemother. 2013 Apr;57(4):1672-6. doi: 10.1128/AAC.02139-12. Epub 2013 Jan 18.

31.

Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.

Maschmeyer G, Heinz WJ, Hertenstein B, Horst HA, Requadt C, Wagner T, Cornely OA, Löffler J, Ruhnke M; IDEA study investigators.

Eur J Clin Microbiol Infect Dis. 2013 May;32(5):679-89. doi: 10.1007/s10096-012-1794-4. Epub 2012 Dec 28.

PMID:
23271674
32.

Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.

Dimopoulos G, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Montravers P, Auzinger G, Sá MB, Miller PJ, Marček T, Kantecki M, Ruhnke M.

Int J Antimicrob Agents. 2012 Dec;40(6):521-6. doi: 10.1016/j.ijantimicag.2012.07.018. Epub 2012 Sep 19.

33.

Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.

Schulz B, Knobloch M, Weber K, Ruhnke M.

Int J Med Microbiol. 2012 Jul;302(3):155-61. doi: 10.1016/j.ijmm.2012.04.002. Epub 2012 Jun 3.

PMID:
22664377
34.

Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Weissinger F, Auner HW, Bertz H, Buchheidt D, Cornely OA, Egerer G, Heinz W, Karthaus M, Kiehl M, Krüger W, Penack O, Reuter S, Ruhnke M, Sandherr M, Salwender HJ, Ullmann AJ, Waldschmidt DT, Wolf HH.

Ann Hematol. 2012 Aug;91(8):1161-74. doi: 10.1007/s00277-012-1456-8. Epub 2012 May 26. Review.

PMID:
22638755
35.

Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.

Oude Lashof AM, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Rex JH, Kullberg BJ.

Antimicrob Agents Chemother. 2012 Jun;56(6):3133-7. doi: 10.1128/AAC.05841-11. Epub 2012 Mar 26.

36.

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.

Ruhnke M, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Menichetti F, Montravers P, Auzinger G, Dimopoulos G, Borges Sá M, Miller PJ, Marček T, Kantecki M.

Clin Microbiol Infect. 2012 Jul;18(7):680-7. doi: 10.1111/j.1469-0691.2012.03784.x. Epub 2012 Mar 8.

37.

Interlaboratory comparison of PCR-based identification of Candida and Aspergillus DNA in spiked blood samples.

Reichard U, Buchheidt D, Lass-Flörl C, Loeffler J, Lugert R, Ruhnke M, Tintelnot K, Weig M, Groß U.

Mycoses. 2012 Sep;55(5):426-34. doi: 10.1111/j.1439-0507.2011.02167.x. Epub 2012 Jan 16.

PMID:
22248125
38.

ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia.

Arendrup MC, Bille J, Dannaoui E, Ruhnke M, Heussel CP, Kibbler C.

Bone Marrow Transplant. 2012 Aug;47(8):1030-45. doi: 10.1038/bmt.2011.246. Epub 2012 Jan 9. Review.

PMID:
22231461
39.

A real-time PCR for the detection and characterisation of Aspergillus species.

Fricke S, Fricke C, Oelkrug C, Blatz R, Schönfelder U, Niederwieser D, Hilger N, Ruhnke M, Rodloff AC.

Mycoses. 2012 Sep;55(5):416-25. doi: 10.1111/j.1439-0507.2011.02161.x. Epub 2011 Dec 11.

PMID:
22151280
40.

Diagnosis of chronic disseminated candidosis from liver biopsies by a novel PCR in patients with haematological malignancies.

Fleischhacker M, Schulz S, Jöhrens K, von Lilienfeld-Toal M, Held T, Fietze E, Schewe C, Petersen I, Ruhnke M.

Clin Microbiol Infect. 2012 Oct;18(10):1010-6. doi: 10.1111/j.1469-0691.2011.03713.x. Epub 2011 Nov 30.

41.

European expert opinion on the management of invasive candidiasis in adults.

Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP.

Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12. doi: 10.1111/j.1469-0691.2011.03615.x.

42.

Diagnosis of invasive fungal infections in hematology and oncology--guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO).

Ruhnke M, Böhme A, Buchheidt D, Cornely O, Donhuijsen K, Einsele H, Enzensberger R, Hebart H, Heussel CP, Horger M, Hof H, Karthaus M, Krüger W, Maschmeyer G, Penack O, Ritter J, Schwartz S; Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology.

Ann Oncol. 2012 Apr;23(4):823-33. doi: 10.1093/annonc/mdr407. Epub 2011 Sep 23. Review.

PMID:
21948809
43.

Influence of doxorubicin on fluconazole susceptibility and efflux pump gene expression of Candida dubliniensis.

Schulz B, Knobloch M, Moran GP, Weber K, Ruhnke M.

Med Mycol. 2012 May;50(4):421-6. doi: 10.3109/13693786.2011.608730. Epub 2011 Sep 22.

PMID:
21939345
44.

Ocular manifestations of candidemia.

Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ.

Clin Infect Dis. 2011 Aug 1;53(3):262-8. doi: 10.1093/cid/cir355.

PMID:
21765074
45.

Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.

Ruhnke M, Rickerts V, Cornely OA, Buchheidt D, Glöckner A, Heinz W, Höhl R, Horré R, Karthaus M, Kujath P, Willinger B, Presterl E, Rath P, Ritter J, Glasmacher A, Lass-Flörl C, Groll AH; German Speaking Mycological Society; Paul-Ehrlich-Society for Chemotherapy.

Mycoses. 2011 Jul;54(4):279-310. doi: 10.1111/j.1439-0507.2011.02040.x. Review.

PMID:
21672038
46.

Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.

Schulz B, Weber K, Schmidt A, Borg-von Zepelin M, Ruhnke M.

Mycoses. 2011 Sep;54(5):e522-30. doi: 10.1111/j.1439-0507.2010.01970.x. Epub 2011 May 23.

PMID:
21605180
47.

Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.

Karthaus M, Rüping MJ, Cornely OA, Steinbach A, Groll AH, Lass-Flörl C, Ostermann H, Ruhnke M, Vehreschild JJ.

Mycoses. 2011 Sep;54(5):e546-56. doi: 10.1111/j.1439-0507.2010.01988.x. Epub 2011 May 10.

PMID:
21554423
48.

Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.

Mikolajewska A, Schwartz S, Ruhnke M.

Mycoses. 2012 Jan;55(1):2-16. doi: 10.1111/j.1439-0507.2010.01961.x. Epub 2011 May 9. Review.

PMID:
21554421
49.

Current issues in the clinical management of invasive aspergillosis--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.

Rüping MJ, Vehreschild JJ, Groll A, Lass-Flörl C, Ostermann H, Ruhnke M, Cornely OA.

Mycoses. 2011 Sep;54(5):e557-68. doi: 10.1111/j.1439-0507.2010.01989.x. Epub 2011 Apr 25.

PMID:
21518025

Supplemental Content

Loading ...
Support Center